Press Releases
Inland Empire Health Plan (IEHP) Brings Together Health Care Leaders at Inaugural Mission Conference
18 November 2019
RANCHO CUCAMONGA, Calif., Nov. 18, 2019 /PRNewswire/ -- In an effort to drive collaboration between Providers and community partners, Inland Empire Health Plan (IEHP) recently hosted a dynamic and thought-provoking conference on the state of health care in the region. The inaugural Mission Conference was held on November 15, 2019
Read more...18 November 2019
PUEBLO, Colo., Nov. 18, 2019 /PRNewswire/ -- Stratos, a Colorado-based cannabis and hemp-infused product manufacturer of tablets, tinctures, and topicals, has bee
Read more...18 November 2019
WASHINGTON, Nov. 18, 2019 /PRNewswire/ -- The statistics are staggering. According to surveys by American College of Emergency Physicians (ACEP) and the Emergency Nurses Association (ENA), almost half of emergency physicians and about 70 percent of emergency nurses have been physically assaulted at work.
Read more...18 November 2019
SALEM, Ore., Nov. 18, 2019 /PRNewswire/ -- Hope Orthopedics of Oregon today announced the addition of fellowship-trained orthopedic surgeon, Dr
Read more...18 November 2019
BOSTON, Nov. 18, 2019 /PRNewswire/ -- The Managing Partners of LTP (Leerink Transformation Partners LLC) Todd Cozzens and Jared Kesselheim, MD announced today the creation of Transformation Capital Partners, L.P. to focus on investing in high-growth digital health companies."With the rapid proliferation of healthcare data,
Read more...MELBOURNE, Australia, Nov. 18, 2019 /PRNewswire/ -- Antisense Therapeutics (ASX: ANP/OTC: ATHJY) is pleased to advise that additional preliminary data analyses from the seven patients who have completed their 24 weeks of dosing in the ATL1102 Phase II DMD clinical trial was presented by Dr Ian Woodcock, the Principle Investigator of the ATL1102 Phase II trial
Read more...18 November 2019
SOUTHLAKE, Texas, Nov. 18, 2019 /PRNewswire/ -- Brain Balance Achievement Centers in
Read more...18 November 2019
CLEVELAND, Nov. 18, 2019 /PRNewswire/ -- Centerline Biomedical, Inc., a spinout company from Cleveland Clinic, announced the successful first human clinical use of its groundbreaking IOPS™ technology.
Read more...18 November 2019
OKLAHOMA CITY, Nov. 18, 2019 /PRNewswire/ -- Novartis has announced that the U.S. Food and Drug Administration approved its new drug to treat sickle cell disease. The therapy, known as Adakveo, is based on discoveries made by Oklahoma Medical Research Foundation physician-scientist Rodger McEver, M.D.FDA approval came following a 52-
Read more...